(Q53845753)

20 May 2018

title

The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. (English)

1 reference

20 May 2018

0 references

Christie E Delaney

1

1 reference

20 May 2018

Brodie T Weagant

series ordinal

2

1 reference

20 May 2018

Christina L Addison

series ordinal

3

1 reference

20 May 2018

language of work or name

English

0 references

publication date

22 April 2006

1 reference

20 May 2018

Experimental Cell Research

published in

1 reference

20 May 2018

volume

312

1 reference

20 May 2018

issue

13

1 reference

20 May 2018

page(s)

2476-2489

1 reference

20 May 2018

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Phase I study of recombinant human endostatin in patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Antiangiogenic activity of endostatin inhibits C6 glioma growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Lack of collagen XVIII/endostatin results in eye abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Interaction of endostatin with integrins implicated in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Endostatin action and intracellular signaling: beta-catenin as a potential target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Cell surface glypicans are low-affinity endostatin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Endostatin is a potential inhibitor of Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Involvement of extracellular matrix constituents in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Increased tenascin expression in melanocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Changes in matrix composition during the growth and regression of human hemangiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Alterations in expression of basement membrane proteins during tumour progression in oral mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Loss of basement membrane components laminin and type IV collagen parallels the progression of oral epithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrins as dynamic regulators of vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrins: bidirectional, allosteric signaling machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrins: versatility, modulation, and signaling in cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Signaling through focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Role of focal adhesion kinase in integrin signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Control of adhesion-dependent cell survival by focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Vitronectin decreases microvascular endothelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Inhibition of endothelial cell survival and angiogenesis by protein kinase A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrin and growth factor receptor crosstalk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.04.003

10.1016/J.YEXCR.2006.04.003

7 January 2021

Identifiers

DOI

1 reference

20 May 2018

1 reference

20 May 2018